Recruiting Pulmonary Embolism Studies in Chesterfield
About Pulmonary Embolism Clinical Trials in Chesterfield
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 1 pulmonary embolism clinical trials recruiting participants in Chesterfield, MISSOURI. These studies are seeking a combined 465 participants. Research is being sponsored by Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Chesterfield — FAQ
Are there pulmonary embolism clinical trials in Chesterfield?
Yes, there are 1 pulmonary embolism clinical trials currently recruiting in Chesterfield, MISSOURI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chesterfield?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chesterfield research site will contact you about next steps.
Are clinical trials in Chesterfield free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chesterfield studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 1 active trials in Chesterfield are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov